Phase 3 Lung Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Adults aged 18 years or older.
- People who have been diagnosed with non-small cell lung cancer (a specific type of lung cancer) confirmed through a tissue or cell sample test.
- People whose cancer has already been treated with at least one previous treatment plan that included both a platinum-based chemotherapy and a type of immunotherapy drug known as a PD-1/PD-L1 inhibitor, and that treatment did not work or stopped working.
- People who have at least one area of cancer in the body that is measurable using standard imaging guidelines (confirm with trial site).
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People whose cancer is driven by certain other known genetic mutations or gene rearrangements for which specific targeted treatments already exist.
- People who have previously received any treatment that specifically targets the KRAS G12C gene mutation.
- People who have previously received a chemotherapy drug called docetaxel for advanced or metastatic disease.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jie Wang, Doctor, Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China
Phone: +86 15720614080
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
PFS
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.